PathogenDx

Arizona-based microarray technology PathogenDx launched its improved rapid semi-quantification assay, QuantX Fungal, which has received an AOAC Performance Tested Methods (PTM) SM Certificate to semi-quantify fungal species in total yeast and mold (TYM) for...

PathogenDx has introduced QuantX Bacterial, a novel four-in-one assay streamlining microbial testing compliance for cannabis laboratories across states. Headquartered in Scottsdale, Arizona, PathogenDx is a leader in next-generation microarray technology for better health and safety...

Arizona-based technology company, PathogenDx, has launched a simple and easy-to-use automated sample preparation system for bacterial and fungal pathogen testing in the cannabis and hemp sectors – Octa AutoPrep Station. PathogenDx The system is compatible with the company’s AOAC-...

PathogenDx, an Arizona-based pathogen-testing technology company, announced this week a strategic partnership with hemp operator and manufacturer Icon Farms. PathogenDx will provide DNA-based customized pathogen testing in order to help standardize and implement microbial safety protocols across a...

PathogenDx, Inc. announced Monday that it raised $7.5 Million in a Series B funding round led by Cresco Capital Partners. The company raised the funds in less than three months with participation from Altitude Investment Management, Arcadian Investment Partners, Panther Opportunity Fund LLC, Salveo...

Money is flowing into the cannabis industry at an unprecedented pace. And it’s not just the Canopy Growth Corp (NYSE: CGC) and Cronos Group Inc (NASDAQ: CRON)’s of the world on the receiving end: public and private companies across the spectrum are drawing ...